Literature DB >> 19629562

Antineuronal antibodies in sporadic late-onset cerebellar ataxia.

K Bürk1, M Wick, G Roth, P Decker, R Voltz.   

Abstract

Sporadic late-onset cerebellar ataxia of unknown cause is considered a neurodegenerative disorder whose underlying mechanisms are still unknown. To identify antineuronal autoantibodies, immunohistochemical and immunoblotting techniques were performed in 67 patients with sporadic cerebellar degeneration of unknown cause. Elevated P/Q-type voltage-gated calcium channel (VGCC)-specific antibodies were found in eight patients (11.9%). There was no hint of a paraneoplastic disorder in any of the patients. The present findings suggest an autoimmune contribution to the pathophysiology of a subgroup of sporadic late-onset cerebellar ataxia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629562     DOI: 10.1007/s00415-009-5262-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

Review 1.  Consensus statement on the diagnosis of multiple system atrophy.

Authors:  S Gilman; P A Low; N Quinn; A Albanese; Y Ben-Shlomo; C J Fowler; H Kaufmann; T Klockgether; A E Lang; P L Lantos; I Litvan; C J Mathias; E Oliver; D Robertson; I Schatz; G K Wenning
Journal:  J Neurol Sci       Date:  1999-02-01       Impact factor: 3.181

Review 2.  Paraneoplastic syndromes involving the nervous system.

Authors:  Robert B Darnell; Jerome B Posner
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

3.  A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.

Authors:  P M Candler; P E Hart; M Barnett; R Weil; J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

Review 4.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

5.  A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer.

Authors:  R Voltz; S H Gultekin; M R Rosenfeld; E Gerstner; J Eichen; J B Posner; J Dalmau
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

6.  Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia.

Authors:  M Hadjivassiliou; R A Grünewald; A K Chattopadhyay; G A Davies-Jones; A Gibson; J A Jarratt; R H Kandler; A Lobo; T Powell; C M Smith
Journal:  Lancet       Date:  1998-11-14       Impact factor: 79.321

7.  "Idiopathic" late onset cerebellar ataxia. A clinical and genetic study of 36 cases.

Authors:  A E Harding
Journal:  J Neurol Sci       Date:  1981-08       Impact factor: 3.181

8.  Magnetic resonance imaging in hereditary and idiopathic ataxia.

Authors:  U Wüllner; T Klockgether; D Petersen; T Naegele; J Dichgans
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

9.  An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.

Authors:  M Motomura; I Johnston; B Lang; A Vincent; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-01       Impact factor: 10.154

10.  Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.

Authors:  V A Lennon; T J Kryzer; G E Griesmann; P E O'Suilleabhain; A J Windebank; A Woppmann; G P Miljanich; E H Lambert
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

View more
  23 in total

Review 1.  Paraneoplastic disorders.

Authors:  Eric Lancaster
Journal:  Continuum (Minneap Minn)       Date:  2015-04

Review 2.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

3.  Paraneoplastic neurological syndromes: general treatment overview.

Authors:  Aurélien Viaccoz; Jérôme Honnorat
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

4.  Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia.

Authors:  R Sivera; N Martín; I Boscá; T Sevilla; N Muelas; I Azorín; J J Vílchez; M Bolonio; E Donat; C Ribes-Koninckx; L Bataller
Journal:  J Neurol       Date:  2011-10-08       Impact factor: 4.849

Review 5.  Movement disorders in paraneoplastic and autoimmune disease.

Authors:  Jessica Panzer; Josep Dalmau
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

Review 6.  Voltage gated calcium channel antibody-related neurological diseases.

Authors:  Can Ebru Bekircan-Kurt; Eda Derle Çiftçi; Aslı Tuncer Kurne; Banu Anlar
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 7.  Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.

Authors:  Eric Lancaster; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

Review 8.  Acquired ataxias: the clinical spectrum, diagnosis and management.

Authors:  Wolfgang Nachbauer; Andreas Eigentler; Sylvia Boesch
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

Review 9.  Update on neurological paraneoplastic syndromes.

Authors:  Romana Höftberger; Myrna R Rosenfeld; Josep Dalmau
Journal:  Curr Opin Oncol       Date:  2015-11       Impact factor: 3.645

Review 10.  Antibodies and neuronal autoimmune disorders of the CNS.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  J Neurol       Date:  2009-12-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.